A detailed history of Yarger Wealth Strategies, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Yarger Wealth Strategies, LLC holds 1,391 shares of ABBV stock, worth $251,965. This represents 0.17% of its overall portfolio holdings.

Number of Shares
1,391
Previous 1,359 2.35%
Holding current value
$251,965
Previous $233,000 17.6%
% of portfolio
0.17%
Previous 0.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$163.84 - $199.33 $5,242 - $6,378
32 Added 2.35%
1,391 $274,000
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $4,334 - $5,061
28 Added 2.1%
1,359 $233,000
Q1 2024

Apr 29, 2024

BUY
$159.82 - $182.1 $5,274 - $6,009
33 Added 2.54%
1,331 $242,000
Q4 2023

Jan 18, 2024

BUY
$137.6 - $154.97 $178,604 - $201,151
1,298 New
1,298 $201,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Yarger Wealth Strategies, LLC Portfolio

Follow Yarger Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yarger Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yarger Wealth Strategies, LLC with notifications on news.